Skip to content

Project VERANDA: Requirement Analysis Survey

Project VERANDA: Requirement Analysis Survey

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07424872
Enrollment
100
Registered
2026-02-20
Start date
2025-05-13
Completion date
2026-05-14
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observational Study

Brief summary

Between 0.6% and 22.2% of the global adult male population has a sexual interest in children (SIIC), depending on evaluation methods \[1\]. SIIC constitutes a major risk factor for child sexual abuse (CSA) and viewing of child sexual abuse material (CSAM). The true rates of CSA offences cannot be estimated, but self-report studies find 30 times higher rates of child-reported CSA compared to reports from child protection services or police. Engagement in therapy is a protective factor against the risk of child sexual abuse and can lead to reductions in CSAM consumption and severity. Anticipated negative therapist behaviour is associated with less willingness to seek treatment. The fear of being reported by the therapist discourages participation in therapy, a concern complicated by mandatory reporting laws in some countries. Negative attitudes towards ISIC are high, and SIIC may be the most stigmatised trait globally. Identifying barriers to treatment for ISIC, and of measures to overcome them, is important to increase therapy engagement, with the goal to improve wellbeing, reduce CSAM consumption, and reduce the risk of CSA offences. Patient anonymity during therapy may play an important role in increasing disclosure of stigmatised traits. It remains unclear whether anonymous therapy addresses patient treatment anxieties and therefore increases the comfort or willingness to engage in therapy. To address this research gap, we conduct an anonymous online survey with ISIC to answer the following questions: RQ1. Can online therapy preferences be identified for minor-attacted individuals and for their therapists? RQ2. Are there individual factors that predict stigmatized individuals' online therapy preferences? (E.g. Trust, Self-Stigma) RQ3. Are there differences between the different stigmatized groups', therapists, and general populations' online therapy preferences?

Detailed description

Participants will receive a study information that describes the aim of the project and a brief overview of data anonymization procedures. This study information is in simple English for comprehesability. Participants will have the option to access more detailed study information, explaining that privacy protections are implemented; tracking technologies are disabled; data will be encrypted and stored on Charité - Universitätsmedizin Berlin servers in compliance with the EU General Data Protection Regulation; and that anonymized data might be shared with academic research institutes within the project consortium. It is also stated that data could be stored for up to three years and that access will be restricted to project members only. To ensure accessibility and comprehensibility for diverse populations, the study information was additionally provided in an easy-to-understand language version. Participants are required to provide informed consent (collected via checkbox without personally-linkable ID) before participation. The questionnaire is available in both German and English. Pilot testing was conducted prior to the main data collection, involving researchers and general members of the public who are not experts in the topic of the study. The pilot study evaluated the comprehensibility, sensitivity, clarity, and overall acceptability of the questionnaire items. In addition, technical functionality and user experience were informally tested across different individuals and devices. This study was approved by the Institutional Ethics Committee of Charité - Universitätsmedizin Berlin (ID EA4\_187\_24). The Charité data protection officewas consulted prior to the start of this study to ensure compliance with applicable data protection regulations, and their advise was implemented. An instance of the survey tool SoSci Survey was hosted on Charité servers. Server-side IP logging disabled are disabled. Within SoSci Survey, cookies and IP-tracking are disabled, and a "Leave and delete my data" button is available for participants prior to final submission of their data. Participants are instructed not to provide any identifiable information either within the Survey or by email to the study team. For preservation of anonymity, consent will be collected only via checkbox, and no records of individual identity were stored. To limit the identifiability of the data through data linkage, demographic information is limited to high-level information rather than specific information, such as country of residence rather than nationality, and age range rather than precise age. We also provide guidelines to participants about how to increase their privacy on the project website (https://project-veranda.github.io/VERANDA/news/How\_to\_protect\_your\_identity/) online. To the best of our efforts, this survey will be conducted anonymously.

Interventions

None listed

Sponsors

Berlin Institute of Health @ Charité
Lead SponsorOTHER
Fraunhofer Institute for Applied and Integrated Security AISEC
CollaboratorUNKNOWN
Deutsches Forschungszentrum für Künstliche Intelligenz GmbH (DFKI)
CollaboratorUNKNOWN
Technische Universität Berlin
CollaboratorOTHER
Charite University, Berlin, Germany
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Belonging to one of the target groups. * Otherwise, for general members of the public, none.

Exclusion criteria

* Younger than 18

Design outcomes

Primary

MeasureTime frameDescription
Preferences of design featuresMay 2025 - May 2026RQ1.1 Can preferences of design features for an online therapy tool be identified for minor-attacted individuals and for their therapists? RQ3.4 Are there differences between the different groups in the preferred choice of consultation technology? Preferences of design features for an online therapy tool: 7-point Likert scale.

Secondary

MeasureTime frameDescription
Preferred choice of consultation methodMay 2025 - May 2026RQ1.2 Can the preferred choice of consultation method be identified? RQ2.3 Does self-stigma, treatment anxiety or trust influence the preferred choice of consultation method? RQ3.3 Are there differences between the different groups in the preferred choice of consultation method? In-person or anonymously online; Individual therapy or group therapy: 7-point bi-directional Likert scale. Responses will be dichotomized into two categories (e.g., "prefer 1-to-1" vs. "prefer group therapy") with neutral responses excluded from the analysis. This results in binary outcome variables.

Countries

Germany

Contacts

CONTACTProf. Dr.-Ing Poikela
maija.poikela@bih-charite.de30 450 528 786

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026